How Fibroscan Technology Is Reshaping Non-Invasive Liver Health Assessment
The Fibroscan Market is on the brink of a transformative era, projected to reach a remarkable volume of USD 167.31 million by 2035. This anticipated growth, fueled by a compound annual growth rate (CAGR) of 5.00%, reflects a significant increase from the current market size of USD 97.8 million in 2024. The momentum is primarily driven by rising awareness surrounding liver health and the...